Vision UK 2013 call for papers

Article

The UK Vision Strategy has opened a call for posters and abstracts for the Vision UK 2013 conference.

The UK Vision Strategy has opened a call for posters and abstracts for the Vision UK 2013 conference.

Vision UK 2013 will be held on 11 June at the Queen Elizabeth II Conference Centre, London, UK. Submissions should be abstracts that focus on the delivery of the UK Vision Strategy objectives and outcomes.

The posters will be on display for delegates to view for the duration of the conference. Awards for the best poster in each category will be presented at the close of the conference. Posters must be sent by 8 April 2013.

Anita Lightstone, UK Vision Strategy Programme Director and VISION 2020 UK Interim Chief Operations Officer, commented, "The posters provide an excellent opportunity for those in the sector to showcase their work and share best practice with their peers. It is through this shared learning that we can continue to develop robust tactics to achieve the UK Vision Strategy aims."

For further details about submissions and guidelines please click here.

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.